• Markets
  • icon
  • Companies
AN1 · ASX

Anagenics Limited (ASX:AN1)

AU$0.019

 0.0 (0.0%)
ASX:Live
01/12/2023 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

AN1 Overview

AN1 Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About AN1

Website

N/A

Telephone

Address

Description

Anagenics Ltd. is a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. It operates through the Anagenics Corporate and Consumer and Health segments. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.

AN1 Price Chart

Key Stats

Market Cap

AU$7.20M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.04

Trade Value (12mth)

AU$430.00

1 week

0%

1 month

-17.39%

YTD

-23.28%

1 year

-33.86%

All time high

8.93546

Key Fundamentals

EPS 3 yr Growth

-78.500%

EBITDA Margin

-17.10%

Operating Cashflow

-$2m

Free Cash Flow Return

-19.20%

ROIC

-18.80%

Interest Coverage

-48.90

Quick Ratio

2.20

Other Data

Shares on Issue (Fully Dilluted)

352m

HALO Sector

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AN1 Announcements

Latest Announcements

Date Announcements

31 October 23

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

31 July 23

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

30 December 22

Application for quotation of securities - AN1

×

Application for quotation of securities - AN1

30 August 23

Appendix 4E and Preliminary Final Report

×

Appendix 4E and Preliminary Final Report

29 November 22

CEO's AGM Address

×

CEO's AGM Address

29 November 22

Results of Meeting

×

Results of Meeting

29 November 22

Constitution

×

Constitution

29 November 22

Final Director's Interest Notice - Eck

×

Final Director's Interest Notice - Eck

29 March 23

CEO Appointment

×

CEO Appointment

28 October 22

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 January 22

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

28 February 23

Change in substantial holding

×

Change in substantial holding

28 February 23

Change in substantial holding from HNG

×

Change in substantial holding from HNG

28 April 23

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

28 April 22

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

27 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

27 November 23

CEO's AGM Presentation

×

CEO's AGM Presentation

27 November 23

Results of Meeting

×

Results of Meeting

27 June 23

FY23 Financial Performance and Business Update

×

FY23 Financial Performance and Business Update

26 October 22

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

26 July 22

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

26 July 22

Advangen Japan Divestment and Earn-Out Agreement

×

Advangen Japan Divestment and Earn-Out Agreement

25 October 23

Notice under Listing Rule 3.10A

×

Notice under Listing Rule 3.10A

25 January 23

Appendix 4C and Quarterly Activity Report

×

Appendix 4C and Quarterly Activity Report

25 August 22

Appendix 4E and FY22 Financial Report

×

Appendix 4E and FY22 Financial Report

24 February 23

Application for quotation of securities - AN1

×

Application for quotation of securities - AN1

24 December 21

Second Supply Agreement for Anagenics' FGF5 Inhibitors

×

Second Supply Agreement for Anagenics' FGF5 Inhibitors

23 September 22

Annual Report to shareholders

×

Annual Report to shareholders

AN1 Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.02 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 40.9 37.1 42.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 45.9 13.5 69.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -49.5 -53.7 -40.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.06 0.04 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.05 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -19.7 -54.6 -31.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 143 211 266 Lock Lock Lock
Basic m Lock Lock Lock Lock 143 211 266 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 6 9 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -20.8 58.8 -1.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 6 9 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 4 5 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.6 36.8 -20.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 63.7 54.8 44.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 36 45 56 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -2 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.6 -71.2 51.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -31.9 -34.4 -17.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -2 -4 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 22.5 -59.1 47.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -39.7 -39.8 -21.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -4 -4 -2 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -4 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.2 6.8 26.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -67.3 -39.5 -29.3 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -3 -2 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -1 -2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 4 0 3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.6 38.3 29.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.7 -0.3 -0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 3 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 13 13 11 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -5 -2 -2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 5 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 10 8 9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 11 9 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.2 -18.9 2.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -29.5 -28.2 -24.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -37.5 -44.0 -30.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -19.5 -33.5 -19.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -33.7 -35.7 -18.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -36.9 -25.0 -19.2 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -33.9 -45.5 -48.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.9 0.5 1.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -50.7 -18.4 -21.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.9 2.4 3.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.6 1.2 2.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 59.6 37.5 41.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -217.7 -69.7 -103.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.2 6.8 9.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.8 1.2 1.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.6 1.8 2.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 11.7 5.4 7.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.4 0.7 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.4 0.7 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -75.7 -44.9 -24.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -33.1 -32.1 -19.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -29.5 -28.2 -24.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.6 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -37.5 -44.0 -30.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -37.5 -44.0 -30.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 445.7 306.3 246.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 115.0 53.7 40.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 560.7 360.0 287.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 135.3 35.6 74.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 425.4 324.3 212.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AN1 Shortsell

Frequently Asked Questions

The current share price of Anagenics Limited (AN1:ASX) is AU$0.019.
The 52-week high share price for Anagenics Limited (AN1:ASX) is AU$0.04.
The 52-week low share price for Anagenics Limited (AN1:ASX)? is AU$0.01.
Anagenics Limited (AN1:ASX) does not pay a dividend.
Anagenics Limited (AN1:ASX) does not pay a dividend.
Anagenics Limited (AN1:ASX) has a franking level of 0%.
Anagenics Limited (AN1:ASX) is classified in the Staples.
The current P/E ratio for Anagenics Limited (AN1:ASX) is .